Stuart Turner

Stuart Turner is currently the TA Head of General Medicines in Global Real World Evidence & Outcomes Research at GSK. Previously, they held various senior roles in real world evidence and outcomes research at Novartis, including Global Real World Evidence Director for Solid Tumors and Executive Director in the same field. Stuart’s extensive experience also includes leadership positions at Regeneron and Rocket Pharmaceuticals, as well as contributions as an Outreach Pharmacist at Melbourne Health, where they focused on chronic disease management and education. They obtained a Bachelor of Pharmacy with Honors from Monash University and a Master's in Public Health with a focus on Health Economics from the University of Melbourne.